Neoleukin Therapeutics
$3.339876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$3.33
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.01 (-0.30%) Today
$0.00 (0.00%) As of 4:00 PM EDT after-hours
Why Robinhood?
You can buy or sell NLTX and other stocks, options, ETFs, and crypto commission-free!
About NLTX
Neoleukin Therapeutics, Inc. Common Stock, also called Neoleukin Therapeutics, is a biopharmaceutical company, which engages in the design of de novo protein therapeutics to address significant unmet medical needs in oncology, inflammation, and autoimmunity. Read More Its lead product candidate, NL-201, is a combined IL-2 and IL-15 agonist designed to eliminate alpha receptor binding. The company was founded by Daniel-Adriano Silva, Carl Walkey, and Umut Ulge in December 2003 and is headquartered in Seattle, WA.
Employees
8
Headquarters
Seattle, Washington
Founded
2003
Market Cap
127.61M
Price-Earnings Ratio
—
Dividend Yield
0.00
Average Volume
127.57K
High Today
$3.42
Low Today
$3.29
Open Price
$3.35
Volume
84.85K
52 Week High
$4.23
52 Week Low
$2.00